Abstract
Tongxinluo (TXL), a widely used traditional Chinese medicine in cardiovascular diseases, has anti-inflammatory and anti-apoptosis effects. However, no studies have explored whether translanted bone-marrow-derived mesenchtmal stem cells pretreated by TXL (MSCTXL) can enhance survival of MSCs thus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have